DigestRedComo funciona
Red
/
Empresas
Ba
No verificado

Bayer

Sobre qué escribimos

FarmacéuticaIndustriaIr de comprasMedicina - VariosSalud

39 Comunicados de prensa

Ver todos los comunicados de prensa
04/04/2025
Legislación/Derecho
Biotecnología
Asociaciones/Profesionales
Sanidad
Salud
Farmacéutica
Bebidas
Agricultura
Materias primas
Venta al público/Minorista
Bayer announces filing of petition to U.S. Supreme Court for review of Durnell Roundup™ case
Fuente
Bayer
Editor
Business Wire
1,00
0
25/03/2025
Análisis de Mercados
Industria
Ciencia
Sanidad
Medicina nuclear
Farmacéutica
Oncología
Fitness
Biotecnología
Salud
Comprehensive Review of More Than 400 Studies Conducted Over 30 Years:
Fuente
Bayer
Editor
Business Wire
1,00
0
25/03/2025
Ferias y Congresos
Industria
Ciencia
Cardiología
Farmacéutica
Salud
Higiene alimentaria
Medicina - Varios
ACC.25: Bayer Presents New Investigational Heart Failure Data and Continued Portfolio Research in Chronic Kidney Disease in Type 2 Diabetes
Fuente
Bayer
Editor
Business Wire
1,00
0
24/03/2025
Mercado laboral
Ciencia
Agricultura
Materias primas
Farmacéutica
Salud
Fitness
Dr. Mike Graham Appointed as New Head of R&D for Bayer’s Crop Science Division
Fuente
Bayer
Editor
Business Wire
1,00
0
17/03/2025
Industria
Ciencia
Higiene alimentaria
Salud
Medicina - Varios
Cardiología
Biotecnología
Farmacéutica
U.S. FDA Accepts Supplemental New Drug Application Under Priority Review for New Indication for KERENDIA® (finerenone) in Patients with Heart Failure with Left Ventricular Ejection Fraction of ≥40%
Fuente
Bayer
Editor
Business Wire
1,00
0
03/03/2025
Bayer Introduces Vyconic™ Soybeans, a Groundbreaking Advance in Weed Management, at Commodity Classic 2025
Fuente
Bayer
Editor
Business Wire
1,00
0
26/02/2025
Oncología
Salud
Medicina nuclear
Medicina - Varios
Farmacéutica
Biotecnología
Industria
Late-breaking data from QUANTI CNS (Central Nervous System) presented at ECR 2025:
Fuente
Bayer
Editor
Business Wire
1,00
0
18/02/2025
Bayer® Aspirin Continues Longstanding Commitment to Heart Health Education, Encouraging Americans to “See Their Risks”
Fuente
Bayer
Editor
Business Wire
1,00
0
13/02/2025
Biotecnología
Farmacéutica
Salud
Oncología
Industria
New Data for NUBEQA® Build on Safety and Efficacy Results Across Subgroups of Patients with Metastatic Hormone-Sensitive Prostate Cancer
Fuente
Bayer
Editor
Business Wire
1,00
0
10/09/2024
Multimedia
Industria
Sanidad
Salud
Farmacéutica
Mundo del espectáculo
Sociedad/Prensa del corazón
Welcome to “Wita”: Claritin® Aims to Take the ‘Itch’ Out of Wichita, the #1 Allergy Capital in the U.S., Just in Time for Fall Allergy Season
Fuente
Bayer
Editor
Business Wire
1,00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0